NSI-189...
阿拉丙酯西酞普兰依地普仑非莫西汀氟苯氧丙胺氟伏沙明茚达品伊福西汀利托西汀鲁巴唑酮OmiloxetineOmiloxetine帕奴拉明帕罗西汀吡喃达明塞罗西汀舍曲林齐美定氯伏胺去甲文拉法辛度洛西汀左旋体米那普仑依氯那明米那普仑西布曲明文拉法辛AmitifadineAmitifadine比西发定BrasofensineBrasofensineBTS-74,398BTS 74,398可卡因双氮奋兴DOV-21,947DOV-21,947DOV-102,677DOV-102,677DOV-216,303DOV-216,303EXP-561EXP-561非唑拉明JNJ-7925476JNJ-7925476NS-2359NS-2359PRC200-SSPRC200-SSPridefinePridefineSEP-225,289SEP-225289SEP-227,162TesofensineTesofensine氨甲达林阿托莫西汀苯奈达林氢苯嘧吲哚达来达林EdivoxetineEdivoxetine恶泼西汀氯他拉明吗吲哚尼索西汀瑞波西汀他洛普仑他舒普仑坦达明维洛沙秦美地沙明伐诺司林阿米庚酸安非他酮西洛巴明ManifaxineManifaxine哌甲酯诺米芬辛RadafaxineRadafaxine他美曲林苯丙胺苯呋拉林二甲磺酸赖右苯丙胺甲基苯丙胺苯乙胺吡贝拉林反苯环丙胺4-Methyl-αMT4-Methyl-AMTαET/Etryptaminealpha-EthyltryptamineαMT/Metryptaminealpha-MethyltryptamineTianeptineTianeptineIndeloxazineIndeloxazineTeniloxazineTeniloxazine曲马多ViqualineViqualineTiazesimTiazesimTofenacinTofenacinAmezepineAmezepineAmineptineAmineptine阿米替林AmitriptylinoxideAmitriptylinoxideAzepindoleAzepindoleButriptylineButriptylineCianopramineCianopramine氯米帕明CotriptylineCotriptylineCyanodothiepinCyanodothiepinDemexiptilineDemexiptilineDepramineDepramineBalipramineBalipramineDesipramineDesipramineDibenzepinDibenzepinDimetacrineDimetacrineDosulepin/DothiepinDosulepinDoxepinDoxepinEnprazepineEnprazepineFluotracenFluotracenHepzidineHepzidineHomopipramolHomopipramolImipramineImipramineImipraminoxideImipraminoxideIntriptylineIntriptylineIprindoleIprindoleKetipramineKetipramineLitracenLitracenLofepramineLofepramineLosindoleLosindoleMariptilineMariptilineMelitracenMelitracenMetapramineMetapramineMezepineMezepineNaranolNaranolNitroxazepineNitroxazepineNortriptylineNortriptylineNoxiptilineNoxiptilineOctriptylineOctriptylineOpipramolOpipramolPipofezinePipofezinePropizepinePropizepineProtriptylineProtriptylineQuinupramineQuinupramineTampramineTampramineTianeptineTianeptineTienopramineTienopramineTrimipramineTrimipramineAmoxapineAmoxapineAptazapineAptazapineAzipramineAzipramineCiclazindolCiclazindolCiclopramineCiclopramineEsmirtazapineEsmirtazapineMaprotilineMaprotilineMazindolMazindol米塞林米氮平OxaprotilineOxaprotilineSetiptiline/TeciptilineSetiptiline阿奈螺酮阿立哌唑贝非拉醇丁螺环酮依他匹隆氟辛克生氟立班丝氨吉哌隆伊沙匹隆奥沙氟生坦度螺酮维拉佐酮扎螺酮世卫基本药物(WHO-EM)撤回臨床試驗第三階段未到第三階段
抗抑郁药物作用機轉不明的藥物煙酰胺促智药哌嗪吡啶
抗抑鬱藥重性抑郁障碍神经退行性疾病國防高等研究計劃署國立衛生研究院海馬迴神經元新生医学导航心理学精神病学心理历程障碍opmpads症状齐名涉及评估治疗N5A5B5C6A6B6D
body.skin-minerva .mw-parser-output table.infobox caption{text-align:center}
系统(IUPAC)命名名称 | |
---|---|
(4-Benzylpiperazin-1-yl)-[2-(3-methylbutylamino)pyridin-3-yl]methanone | |
临床数据 | |
妊娠分级 |
|
给药途径 | Oral[1] |
合法狀態 | |
合法状态 |
|
药代动力学数据 | |
生物半衰期 | 17.4–20.5 hours[1] |
识别信息 | |
CAS注册号 | 1270138-40-3 |
PubChem | CID 50922681 |
ChemSpider | 32701740 |
化学信息 | |
化学式 | C22H30N4O |
摩尔质量 | 366.4998 g/mol |
SMILES
| |
InChI
|
NSI-189是一個實驗性藥物,由Neuralstem, Inc.開發的抗抑鬱藥。用於治療重性抑郁障碍 (MDD), 認知障礙以及神经退行性疾病.[2][1][3] 相關研究由美國國防高等研究計劃署 (DARPA)以及國立衛生研究院 (NIH)出資。[4] NSI-189的作用機轉為在海馬迴增強的神經元新生以及其體積的增大,[2]但NSI-189達成此效果的機轉尚不明朗。配體結合研究目前為止無法找出其標靶[3]。
此藥物由對10,269種化合物進行高通量篩檢而發現,其過程為尋找in vitro環境下有神經新生特性的化合物。[3]
參見
4-Chlorokynurenine (AV-101)
Buprenorphine/samidorphan (ALKS-5461)- CERC-301
CERC-501 (LY-2456302)
Dextromethorphan/quinidine (AVP-786/AVP-923)- Esketamine
- Ketamine
- NRX-1074
Rapastinel (GLYX-13)
參考資料
^ 1.01.11.2 Fava, M; Johe, K; Ereshefsky, L; Gertsik, L G; English, B A; Bilello, J A; Thurmond, L M; Johnstone, J; Dickerson, B C; Makris, N; Hoeppner, B B; Flynn, M; Mischoulon, D; Kinrys, G; Freeman, M P. A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients. Molecular Psychiatry. 2015. ISSN 1359-4184. doi:10.1038/mp.2015.178.
^ 2.02.1 Eric E. Bouhassira. The SAGE Encyclopedia of Stem Cell Research. SAGE Publications. 15 June 2015: 843–. ISBN 978-1-4833-4767-7.
^ 3.03.13.2 Neuralstem, Neuralstem Inc. March 2016 Corporate Presentation (PDF), March 2016 [25 March 2016] [永久失效連結]
^ FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder[永久失效連結]
|